SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN) a late clinical-stage neuroscience-focused biopharmaceutical company dedicated to the development and commercialization of ...
As the Circular Action Alliance (CAA), Washington, enters a critical phase of making its comprehensive strategy for California’s extended producer responsibility (EPR) law, Senate Bill 54, the ...
Neuphoria Therapeutics Inc.’s phase III study of social anxiety disorder has missed its primary and secondary endpoints, prompting the company to stop the program’s development and hold a full ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback